Is Medtronic (MDT) overvalued or fairly valued?

MarketChacha shows Medtronic's valuation in context — a forward P/E of about 13.0, a price-to-book of about 2.2 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of Medtronic (MDT)?

Medtronic last traded at $83.29 (+0.1% on the day), as of 7/20/2026 — a delayed quote shown for education, not investment advice.

Medtronic

MDT · NYSE · MedTech · United States

$83.29+0.1%

Delayed · as reported by Yahoo Finance · as of Jul 20, 2026, 8:00 PM

Snapshot

TickerMDT

ExchangeNYSE

SectorMedTech

IndustryMedical Devices

CountryUnited States

Employees95,000

HeadquartersGalway, Ireland

Market cap$106.6B

P/B2.2

Volume5.55M

Websitewww.medtronic.com

Filings tracked0

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Profile as reported by Yahoo Finance.

Who owns it

Insiders0.3%
Institutions89.5%
Public & other10.2%

2,982 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.8.84%
Vanguard Capital Management LLC6.51%
State Street Corporation4.82%
JPMORGAN CHASE & CO3.98%
Capital Research Global Investors3.28%
Vanguard Portfolio Management LLC2.61%
Geode Capital Management, LLC2.24%
Bank of America Corporation2.03%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $9.5B · EPS 1.35

Est. earnings growth -1.0%

Next fiscal year

Rev $40.2B · EPS 6.40

Est. earnings growth +7.7%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$73.3152-wk range$106.33

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about MDT

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.